Fund Overview of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth
-
₹6,104.0 CrAUM
-
₹40.11NAV
-
1.87%Expense Ratio
-
EquityFund Category
Returns of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 1.84% | NA | 6.12% |
| 6 Months | 17.14% | NA | 12.92% |
| 1 Year | 4.06% | 4.06% | 6.04% |
| 2 Years | 68.49% | 29.80% | 24.93% |
| 3 Years | 109.23% | 27.90% | 25.71% |
| 5 Years | 148.83% | 20.00% | 19.91% |
| 7 Years | 295.75% | 21.72% | NA |
Asset Allocation
equities
97.10%other assets or cash equivalents
2.90%ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth is one Equity mutual fund offered by ICICI Prudential Mutual Fund. Launched on 13 Jul 2018, the fund aims Long term wealth creation. An equity Scheme that predominantly invests in pharma, healthcare, hospitals, diagnostics, wellness and allied companies. It manages assets worth ₹6,104.0 crore as on Thu Jul 31, 2025. , with a 52-week NAV range between ₹33.80 and ₹41.47. The expense ratio stands at 1.87%. Fund Manager Manager Education Fund Manager Manager EducationAbout ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth
The portfolio allocation consists of 97.10% in equities, 2.90% in other assets or cash equivalents. Managed by Dharmesh Kakkad, it has delivered a return of 4.06% in the last year, a total return since inception of 21.26%.
Key Metrics of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth
-
Standard Deviation15.51%
-
Sharpe Ratio1.27%
-
Alpha3.55%
-
Beta0.94%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | -0.73% | -1.14% | 6.20% | 28.02% | 21.10% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | -0.79% | -1.33% | 5.36% | 26.93% | 20.05% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -0.20% | -1.78% | 1.78% | 22.39% | 17.07% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -0.32% | -2.11% | 0.45% | 20.74% | 15.41% |
More funds from ICICI Prudential Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth
|
₹6,104 | -0.73% | -1.14% | 5.37% | 6.20% | 28.02% |
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw
|
₹6,104 | -0.79% | -1.33% | 4.95% | 5.36% | 26.93% |
|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw
|
₹6,104 | -0.73% | -1.14% | 5.37% | 6.20% | 28.02% |
|
ICICI Prudential Nifty Healthcare Etf - Growth
|
₹146 | -0.43% | 0.31% | 6.23% | 5.45% | 21.89% |
|
ICICI Prudential Nifty Pharma Index Fund - Growth
|
₹95 | 0.97% | 0.73% | 5.31% | 1.63% | - |
|
ICICI Prudential Nifty Pharma Index Fund Direct - Growth
|
₹95 | 1.02% | 0.88% | 5.64% | 2.23% | - |
|
ICICI Prudential Nifty Pharma Index Fund - Idcw
|
₹95 | 0.97% | 0.73% | 5.31% | 1.63% | - |
|
ICICI Prudential Nifty Pharma Index Fund Direct - Idcw
|
₹95 | 1.02% | 0.88% | 5.64% | 2.23% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.11 | 26.93% | 20.05% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.33 | 28.02% | 21.10% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.25 | 22.39% | 17.07% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.05 | 20.74% | 15.41% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹151.38 | 21.89% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.18 | 22.06% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.88% | ₹764.80 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.88% | ₹764.80 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.58% | ₹721.19 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.69% | ₹713.48 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.42% | ₹606.54 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.42% | ₹606.54 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 9.10% | ₹566.95 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.50% | ₹547.49 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.50% | ₹547.49 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.75% | ₹544.91 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 8.85% | ₹540.22 Cr |
| Aurobindo Pharma Ltd | Healthcare | 8.25% | ₹513.73 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.13% | ₹496.29 Cr |
| Aurobindo Pharma Ltd | Healthcare | 7.62% | ₹490.41 Cr |
| Aurobindo Pharma Ltd | Healthcare | 7.62% | ₹490.41 Cr |
| Cipla Ltd | Healthcare | 7.54% | ₹460.34 Cr |
| Cipla Ltd | Healthcare | 6.92% | ₹430.94 Cr |
| Cipla Ltd | Healthcare | 6.61% | ₹425.53 Cr |
| Cipla Ltd | Healthcare | 6.61% | ₹425.53 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.71% | ₹348.35 Cr |
| Lupin Ltd | Healthcare | 5.40% | ₹347.47 Cr |
| Lupin Ltd | Healthcare | 5.40% | ₹347.47 Cr |
| Lupin Ltd | Healthcare | 5.43% | ₹338.23 Cr |
| Lupin Ltd | Healthcare | 5.11% | ₹312.02 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.98% | ₹256.14 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.98% | ₹256.14 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.05% | ₹252.35 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.88% | ₹236.58 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.83% | ₹234.03 Cr |
| Biocon Ltd | Healthcare | 3.64% | ₹222.32 Cr |
| Repo | Unspecified | 3.60% | ₹220.04 Cr |
| Biocon Ltd | Healthcare | 3.28% | ₹211.36 Cr |
| Biocon Ltd | Healthcare | 3.28% | ₹211.36 Cr |
| Repo | Unspecified | 3.18% | ₹204.95 Cr |
| Repo | Unspecified | 3.18% | ₹204.95 Cr |
| Gland Pharma Ltd | Healthcare | 3.20% | ₹195.59 Cr |
| Biocon Ltd | Healthcare | 3.11% | ₹193.70 Cr |
| Gland Pharma Ltd | Healthcare | 2.97% | ₹184.82 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.95% | ₹183.41 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.97% | ₹181.51 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.79% | ₹179.51 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.79% | ₹179.51 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.78% | ₹172.94 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.67% | ₹171.62 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.67% | ₹171.62 Cr |
| Repo | Unspecified | 2.58% | ₹160.51 Cr |
| Syngene International Ltd | Healthcare | 2.50% | ₹152.34 Cr |
| Syngene International Ltd | Healthcare | 2.23% | ₹143.42 Cr |
| Syngene International Ltd | Healthcare | 2.23% | ₹143.42 Cr |
| Syngene International Ltd | Healthcare | 2.21% | ₹137.41 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.08% | ₹134.20 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.08% | ₹134.20 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.03% | ₹130.62 Cr |
| Thyrocare Technologies Ltd | Healthcare | 2.03% | ₹130.62 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.91% | ₹123.26 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.91% | ₹123.26 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.77% | ₹113.91 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.77% | ₹113.91 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.81% | ₹112.88 Cr |
| Gland Pharma Ltd | Healthcare | 1.72% | ₹110.91 Cr |
| Gland Pharma Ltd | Healthcare | 1.72% | ₹110.91 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.70% | ₹106.15 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 1.72% | ₹105.07 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.64% | ₹102.33 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.62% | ₹99.17 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.51% | ₹97.36 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.51% | ₹97.36 Cr |
| Pfizer Ltd | Healthcare | 1.46% | ₹94.27 Cr |
| Pfizer Ltd | Healthcare | 1.46% | ₹94.27 Cr |
| Pfizer Ltd | Healthcare | 1.54% | ₹94.00 Cr |
| Sagility India Ltd. | Industrials | 1.53% | ₹93.24 Cr |
| Pfizer Ltd | Healthcare | 1.46% | ₹91.14 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.43% | ₹89.21 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.44% | ₹88.17 Cr |
| Medplus Health Services Ltd | Healthcare | 1.43% | ₹87.20 Cr |
| Thyrocare Technologies Ltd | Healthcare | 1.39% | ₹86.75 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.34% | ₹86.33 Cr |
| Metropolis Healthcare Ltd | Healthcare | 1.34% | ₹86.33 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.40% | ₹85.55 Cr |
| Windlas Biotech Ltd | Healthcare | 1.39% | ₹84.83 Cr |
| Sagility India Ltd. | Industrials | 1.31% | ₹81.29 Cr |
| Windlas Biotech Ltd | Healthcare | 1.26% | ₹81.09 Cr |
| Windlas Biotech Ltd | Healthcare | 1.26% | ₹81.09 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.32% | ₹80.84 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 1.32% | ₹80.79 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.29% | ₹80.13 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.31% | ₹79.91 Cr |
| Fine Organic Industries Ltd | Materials | 1.31% | ₹79.67 Cr |
| Medplus Health Services Ltd | Healthcare | 1.23% | ₹79.11 Cr |
| Medplus Health Services Ltd | Healthcare | 1.23% | ₹79.11 Cr |
| Aarti Drugs Ltd | Healthcare | 1.28% | ₹78.18 Cr |
| Windlas Biotech Ltd | Healthcare | 1.25% | ₹77.69 Cr |
| Fine Organic Industries Ltd | Materials | 1.17% | ₹75.61 Cr |
| Fine Organic Industries Ltd | Materials | 1.17% | ₹75.61 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.17% | ₹75.12 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.17% | ₹75.12 Cr |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 1.23% | ₹74.82 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.16% | ₹74.75 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.16% | ₹74.75 Cr |
| Aarti Drugs Ltd | Healthcare | 1.19% | ₹73.99 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.19% | ₹73.97 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.14% | ₹73.63 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.14% | ₹73.63 Cr |
| Aarti Drugs Ltd | Healthcare | 1.14% | ₹73.09 Cr |
| Aarti Drugs Ltd | Healthcare | 1.14% | ₹73.09 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.17% | ₹72.54 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.11% | ₹71.64 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 1.11% | ₹71.64 Cr |
| Medplus Health Services Ltd | Healthcare | 1.14% | ₹70.98 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.16% | ₹70.77 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 1.14% | ₹70.69 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 1.10% | ₹68.39 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.06% | ₹67.97 Cr |
| Shilpa Medicare Ltd | Healthcare | 1.06% | ₹67.97 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.09% | ₹67.88 Cr |
| Fine Organic Industries Ltd | Materials | 1.08% | ₹67.35 Cr |
| Star Health & Allied Insurance Co. Ltd | Financial | 1.07% | ₹65.18 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 1.04% | ₹63.43 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.91% | ₹58.78 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.91% | ₹58.78 Cr |
| Advanced Enzyme Technologies Ltd | Materials | 0.95% | ₹58.10 Cr |
| Fdc Ltd | Healthcare | 0.94% | ₹57.41 Cr |
| Emcure Pharmaceuticals Ltd. | Healthcare | 0.92% | ₹57.05 Cr |
| Fdc Ltd | Healthcare | 0.86% | ₹55.17 Cr |
| Fdc Ltd | Healthcare | 0.86% | ₹55.17 Cr |
| Hikal Ltd | Healthcare | 0.84% | ₹54.22 Cr |
| Hikal Ltd | Healthcare | 0.84% | ₹54.22 Cr |
| Fdc Ltd | Healthcare | 0.85% | ₹52.97 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.82% | ₹52.57 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.82% | ₹52.57 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.84% | ₹52.28 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.85% | ₹51.87 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.79% | ₹51.17 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.79% | ₹51.17 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.83% | ₹50.54 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.78% | ₹50.51 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.78% | ₹50.51 Cr |
| Astrazeneca Pharma India Ltd | Healthcare | 0.80% | ₹50.10 Cr |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 0.80% | ₹49.88 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.77% | ₹49.42 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.77% | ₹49.42 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.77% | ₹47.78 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.75% | ₹45.99 Cr |
| Rubicon Research Ltd. | 0.69% | ₹44.61 Cr | |
| Rubicon Research Ltd. | 0.69% | ₹44.61 Cr | |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.72% | ₹44.15 Cr |
| Senores Pharmaceuticals Ltd. | Healthcare | 0.71% | ₹44.10 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.68% | ₹44.07 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.68% | ₹44.07 Cr |
| Sagility India Ltd. | Industrials | 0.66% | ₹42.22 Cr |
| Sagility India Ltd. | Industrials | 0.66% | ₹42.22 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.67% | ₹40.87 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.63% | ₹40.50 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.63% | ₹40.50 Cr |
| Sun Pharma Advanced Research Company Ltd | Healthcare | 0.61% | ₹38.29 Cr |
| Hikal Ltd | Healthcare | 0.44% | ₹27.60 Cr |
| Net Current Assets | Unspecified | 0.37% | ₹22.68 Cr |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | 0.24% | ₹15.05 Cr |
| Cash Margin | Unspecified | 0.14% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Cash Margin | Unspecified | 0.13% | ₹8.41 Cr |
| Advanced Enzyme Technologies Ltd | Materials | 0.07% | ₹4.47 Cr |
| Ipca Laboratories Ltd | Healthcare | 0.01% | ₹0.62 Cr |
| Net Payables | Unspecified | -0.26% | ₹-16.22 Cr |
| Net Payables | Unspecified | -0.41% | ₹-26.44 Cr |
| Net Payables | Unspecified | -0.41% | ₹-26.44 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.33 | 28.02% | 21.10% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.11 | 26.93% | 20.05% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.25 | 22.39% | 17.07% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.05 | 20.74% | 15.41% | - |
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth
What is the current AUM of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth?
As of Thu Jul 31, 2025, ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth manages assets worth ₹6,104.0 crore
How has ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth performed recently?
- 3 Months: 1.84%
- 6 Months: 17.14%
What is the long-term performance of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth?
- 3 Years CAGR: 27.90%
- 5 Years CAGR: 20.00%
- Since Inception: 21.26%
What is the portfolio composition of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth?
Equity: 97.10%, Others: 2.90%.
Who manages ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth?
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth is managed by Dharmesh Kakkad from ICICI Prudential Mutual Fund.
What is the market-cap allocation of ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth?
Large Cap: 48.68%, Mid Cap: 17.67%, Small Cap: 33.65%.
Which are the top companies ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth has invested in?
- Sun Pharmaceutical Industries Ltd – 11.88% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.88% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.58% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 11.69% of the fund's portfolio
- Dr. Reddy's Laboratories Ltd – 9.42% of the fund's portfolio
Which are the major sectors ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth focuses on?
- Healthcare – 364.88% of the fund's portfolio
- Unspecified – 12.37% of the fund's portfolio
- Industrials – 11.11% of the fund's portfolio
- Materials – 5.76% of the fund's portfolio
- Financial – 4.49% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.


